Temozolomide–Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy
Author:
Affiliation:
1. Key Laboratory of High Performance Polymer Material and Technology of Ministry of Education, Department of Polymer Science & Engineering, School of Chemistry & Chemical Engineering, Nanjing University, Nanjing 210023, China
Funder
Ministry of Education of the People's Republic of China
Ministry of Science and Technology of the People's Republic of China
Publisher
American Chemical Society (ACS)
Subject
General Materials Science
Link
https://pubs.acs.org/doi/pdf/10.1021/acsami.0c08531
Reference69 articles.
1. Glioblastoma multiforme: The terminator
2. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment
3. Current state of immunotherapy for glioblastoma
4. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma
5. Oncolytic Virus Therapy for Glioblastoma Multiforme
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hydroxychloroquine loaded hollow apoferritin nanocages for cancer drug repurposing and autophagy inhibition;European Journal of Pharmaceutics and Biopharmaceutics;2024-10
2. Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice;2024-06-10
3. The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening;Scientific Reports;2024-02-14
4. Temozolomide and Doxorubicin Combined Treatment by Graphene Oxide-Cyclodextrin Nanocarriers for Synergistic Inhibition of Glioblastoma Cells;BioNanoScience;2024-01-18
5. Encapsulation of copper phenanthroline within horse spleen apoferritin: characterisation, cytotoxic activity and ability to retain temozolomide;RSC Advances;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3